Every pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of customers, and deposits hefty profits in drugmakers ...

Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate ...

California lawmakers could soon clear a logjam that has held up studies related to addiction treatment, psychedelics or other ...

The global human growth hormone treatment and drugs market has exhibited a valuation of USD 3.55 Billion by the end of 2022, ...

The US FDA has granted fast track designation for iECURE’s ECUR-506 for the treatment of neonatal onset ornithine transcarbamylase deficiency.

A committee of independent advisers to the Food and Drug Administration will meet on June 4 to review data supporting the new ...

Measure 110, the landmark statewide drug decriminalization initiative that Oregon passed in 2020 with 58 percent of the vote, had no sooner gotten off the ground than its most prominent plank—which ...

One analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing investors its drug seralutinib can compete on the market.

Women taking Ozempic or similar drugs for diabetes or weight loss are taking to social media to commiserate about an ...

Negative stigma surrounding drug addiction must be changed so addicts can receive treatment and professional support, says ...

An experimental anti-nicotine drug appears to help people quit vaping, a new study says. Cytisinicline is a naturally occurring plant-based substance that binds to nicotine receptors in the brain, ...

A drug used for the treatment of pancreatic cancer can be repurposed to replace insulin therapy among people with diabetes, ...